Median salary
$97,478
per year · annualized USD
Typical range
$70.7k – $132.6k
25th–75th percentile
Disclosing pay
37.1%
605 of 1,631 roles
Live roles
1,631
open right now
Trend builds as new salary snapshots accrue — check back soon.
Senior Clinical Research Associate - Oncology (US)
Principal Scientist / Associate Director, Agentic AI Research for Materials Science
Associate Principal, Patient-Centered Research
Postdoctoral Research Associate - Uncertainty Modeling
Postdoctoral Research Associate
Associate Director, Health Economics & Outcomes Research, Solid Tumors
Associate Medical Director, Clinical Research
Associate Medical Director, Clinical Research
| Company | Median | Roles |
|---|---|---|
The University of Texas at Austin
|
$52,750 | 40 |
| WC Worldwide Clinical Trials | $145,000 | 35 |
IQVIA
|
$131,750 | 35 |
| NU Northeastern University | $72,754 | 31 |
ICON plc
|
$124,335 | 27 |
USC
|
$71,319 | 18 |
| FO Fortrea | $110,000 | 16 |
Bank of America
|
$142,500 | 14 |
See every Biotech Research role
Browse the live listings, or save this search and get alerted the moment a new one posts.
The median salary for Full-time Biotech Research roles is $97,478 per year. Most pay falls between $70,666 (25th percentile) and $132,575 (75th percentile), with the broader 10th–90th percentile band running from $55,000 to $152,500.
These figures are computed live from 1,631 active Full-time Biotech Research roles on JobsRadar, of which 605 (37.1%) publish a salary range. Pay is normalized to annualized USD so roles can be compared on equal terms; the highest-paying roles listed above show their original posted currency. Numbers refresh every few hours as new roles are posted and older ones close.
Employers currently hiring well-paid Full-time Biotech Research roles include Worldwide Clinical Trials, Lila Sciences, IQVIA and University System of New Hampshire.
Salary transparency varies by employer and region, so the disclosing share above reflects only roles that publish pay — not every open position. Use it as a directional benchmark rather than an exact offer.